Benign breast disease resolved and unresolved issues

J. Connolly,S. Schnitt

DOI: https://doi.org/10.1002/1097-0142(19930215)71:4<1187::AID-CNCR2820710402>3.0.CO;2-V

IF: 6.9209

1993-02-15

Cancer

Abstract:In this issue of Cancer, Dupont and colleagues report the results of a case-control study relating pathologic findings in benign breast biopsies to the risk breast cancer development in a cohort of women enrolled in the Breast Cancer Detection Demonstration Project (BCDDP).' This is the third large study performed in the United States to assess the relationship between benign breast disease and subsequent breast cancer risk using the same histologic classification system for cate-gorizing benign breast lesions. The first of these studies was a retrospective cohort study of women in Nashville who had one or more benign breast biopsies and for whom long-term follow-up was available.2 The second was a case-control study of a subset of women participating in the Nurses' Health Study (NHS).3 The studies performed by the BCDDP and NHS groups were undertaken in response to a proposal issued by the National Institutes of Health (NIH) to determine if the results obtained in Dupont and Page's initial study of women in Nashville could be duplicated by other pathologists in different cohorts of women.